Help Ensure Your Pradaxa Patients Don't Need the New Reversal Agent, Praxbind

You'll hear buzz about the new IV med, Praxbind (PRAKS-bynd, idarucizumab) to reverse life-threatening bleeding caused by Pradaxa....

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote